| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8662700 | International Journal of Cardiology | 2018 | 8 Pages |
Abstract
Treatment with lower-dose RLX in mice prevents post-infarction ventricular tachycardia due to attenuation of scar formation and cardiac inflammation. Therefore, RLX could be evaluated as new therapeutic option in the treatment of MI.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Thomas Beiert, Vincent Knappe, Vedat Tiyerili, Florian Stöckigt, Verena Effelsberg, Markus Linhart, Martin Steinmetz, Sabine Klein, Robert Schierwagen, Jonel Trebicka, Wilhelm Roell, Georg Nickenig, Jan W. Schrickel, René P. Andrié,